CCTG MA.39/Tailor RT (Breast Cancer) - Clinical Trial

What is the Purpose of this Study?

We are doing this study to find out if women with a type of low risk breast cancer need to receive regional radiation therapy.

What is the Condition Being Studied?

Biomarker low risk node positive breast cancer

Who Can Participate in the Study?

-Adults, 40 years or older
-Have had breast conserving surgery or mastectomy

Age Group
Adults

What is Involved?

If you choose to join this study, you will:
- Be randomized (like flipping a coin) into Group 1 or Group 2:
--Group 1 will go as follows:
----If you had surgery to remove part of the breast, you will get radiation aimed at the breast only
----If you had surgery to remove the whole breast you will receive no radiation
therapy

--Group 2 will go as follows:
----If you had surgery to remove part of the breast, you will receive radiation aimed at the breast only and additional radiation aimed at the surrounding lymph glands
----If you had surgery to remove the whole breast you will receive radiation aimed at the chest area and the surrounding lymph glands

Study Details

Full Title
CCTG MA.39/Tailor RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
Principal Investigator
Radiation Oncologist
Protocol Number
IRB: PRO00102549
NCT: NCT03488693
Phase
Phase N/A
ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698